Novel OAB treatment vibegron does not adversely affect blood pressure

In this video, Michael A. Weber, MD, discusses the background and findings of the study, “Effects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind study,” presented at the 2021 American Urological Association Annual Meeting. Weber is a professor of medicine and associate dean of research at Downstate College of Medicine, State University of New York, Brooklyn, New York.

Related Videos
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Patient predictors of postprostatectomy incontinence | Image credit: © jakkapan - stock.adobe.com
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Dr. Woodburn in an interview with Urology Times
Dean Elterman, MD, MSc, FRCSC, in an interview with Urology Times
Anjali Kapur, MD, looks at the camera while answering a question
Anjali Kapur, MD, answers a question about a recent study regarding third-line treatments for OAB
jakkapan - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.